Activity ID



April 21, 2025

Format Type


CME Credit




CME Provider: American Medical Association

Description of CME Course

The same medications and treatments are not universally effective for every patient. As consumer knowledge of genetics increases, more patients will be coming to you with a direct-to-consumer (DTC) genetics test in hand. What expectations will your patients have? How does Pharmacogenomics (PGx) data help us determine which medication will work better for a specific patient? This course will answer those questions by framing PGx from the perspective of the patient.


1. This activity is accredited by the American Medical Association.
2. This activity is free to AMA members.

Register for this Activity

ABMS Member Board Approvals by Type
More Information
Commercial Support?

NOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.

Educational Objectives

1. Recognize drivers for implementation of pharmacogenomics from the patient's perspective
2. Identify common patient communication challenges regarding PGx
3. Explain common pharmacogenomic equity opportunities and challenges


Adverse Drug Events, Pharmacogenetics, Clinical Pharmacy and Pharmacology


Medical Knowledge

CME Credit Type

AMA PRA Category 1 Credit



View All Activities by this CME Provider

The information provided on this page is subject to change. Please refer to the CME Provider’s website to confirm the most current information.